Feb 13, 2014
U.S. District Court Judge Terence Kern issued the order in response to a lawsuit from Michael Taylor, who is scheduled to die on February 26th. Taylor's attorneys charged that the drug pentobarbital, supplied by The Apothecary Shoppe that contracts with the state of Missouri, would cause "severe, unnecessary, lingering and ultimately inhumane pain" to their client.
The attorneys invoked evidence that this experimental drug, which many states are turning to amid shortages of execution drugs, caused severe pain when used in recent executions. This includes the statement by Michael Lee Wilson, who was on death row in Oklahoma, that he could feel his "whole body burning" just seconds after receiving the lethal injection on January 9th.
Kern scheduled an evidentiary hearing for Tuesday. It is not clear if Taylor's execution will be delayed.
_____________________
Why Your Ongoing Support Is Essential
Donald Trump’s attacks on democracy, justice, and a free press are escalating — putting everything we stand for at risk. We believe a better world is possible, but we can’t get there without your support. Common Dreams stands apart. We answer only to you — our readers, activists, and changemakers — not to billionaires or corporations. Our independence allows us to cover the vital stories that others won’t, spotlighting movements for peace, equality, and human rights. Right now, our work faces unprecedented challenges. Misinformation is spreading, journalists are under attack, and financial pressures are mounting. As a reader-supported, nonprofit newsroom, your support is crucial to keep this journalism alive. Whatever you can give — $10, $25, or $100 — helps us stay strong and responsive when the world needs us most. Together, we’ll continue to build the independent, courageous journalism our movement relies on. Thank you for being part of this community. |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
U.S. District Court Judge Terence Kern issued the order in response to a lawsuit from Michael Taylor, who is scheduled to die on February 26th. Taylor's attorneys charged that the drug pentobarbital, supplied by The Apothecary Shoppe that contracts with the state of Missouri, would cause "severe, unnecessary, lingering and ultimately inhumane pain" to their client.
The attorneys invoked evidence that this experimental drug, which many states are turning to amid shortages of execution drugs, caused severe pain when used in recent executions. This includes the statement by Michael Lee Wilson, who was on death row in Oklahoma, that he could feel his "whole body burning" just seconds after receiving the lethal injection on January 9th.
Kern scheduled an evidentiary hearing for Tuesday. It is not clear if Taylor's execution will be delayed.
_____________________
U.S. District Court Judge Terence Kern issued the order in response to a lawsuit from Michael Taylor, who is scheduled to die on February 26th. Taylor's attorneys charged that the drug pentobarbital, supplied by The Apothecary Shoppe that contracts with the state of Missouri, would cause "severe, unnecessary, lingering and ultimately inhumane pain" to their client.
The attorneys invoked evidence that this experimental drug, which many states are turning to amid shortages of execution drugs, caused severe pain when used in recent executions. This includes the statement by Michael Lee Wilson, who was on death row in Oklahoma, that he could feel his "whole body burning" just seconds after receiving the lethal injection on January 9th.
Kern scheduled an evidentiary hearing for Tuesday. It is not clear if Taylor's execution will be delayed.
_____________________
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.